β1 is also involved in tamoxifen resistance, and fibroblasts, derived from an estrogen-dependent, spontaneous mammary tumor, produce soluble factors inducing tamoxifen resistance in the epithelial cells through activation of EGFR, PI3K/AKT and β1. Here, AKT1 is linked to breast cancer.